Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Rutgers, The State University of New Jersey
University of Pittsburgh
SWOG Cancer Research Network
IFOM ETS - The AIRC Institute of Molecular Oncology
City of Hope Medical Center
Myriad Genetic Laboratories, Inc.
UNC Lineberger Comprehensive Cancer Center
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC